Tygh Capital Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-40,926
Closed -$2.96M 93
2016
Q2
$2.96M Sell
40,926
-37,482
-48% -$2.58M 0.83% 57
2016
Q1
$5.07M Sell
78,408
-311
-0.4% -$20.6K 1.48% 18
2015
Q4
$5.64M Sell
78,719
-34,308
-30% -$2.54M 1.58% 19
2015
Q3
$8.68M Sell
113,027
-41,838
-27% -$3.38M 2.06% 2
2015
Q2
$11.5M Buy
154,865
+27,279
+21% +$1.96M 2.05% 2
2015
Q1
$9.25M Sell
127,586
-1,967
-2% -$137K 1.7% 9
2014
Q4
$8.56M Buy
129,553
+6,832
+6% +$417K 1.66% 9
2014
Q3
$6.73M Buy
122,721
+42,509
+53% +$2.41M 1.47% 14
2014
Q2
$4.66M Sell
80,212
-5,059
-6% -$298K 0.99% 42
2014
Q1
$5.29M Sell
85,271
-43,419
-34% -$2.53M 1.08% 38
2013
Q4
$6.87M Sell
128,690
-3,790
-3% -$203K 1.44% 16
2013
Q3
$6.65M Sell
132,480
-76,202
-37% -$3.72M 1.49% 12
2013
Q2
$9.56M Buy
+208,682
New +$9.34M 2.12% 5

Other funds holding MD

Tygh Capital Management's MD Position: Q3 2016 in Review

Tygh Capital Management sold out of Pediatrix Medical (MD) in Q3 2016, closing a stake of 40,926 shares — an estimated $2.96M sold.

Tygh Capital Management first reported a position in MD in Q2 2013 and held it in 13 quarters. The position peaked at $11.5M in Q2 2015. 381 funds tracked by Wall St. Rank hold MD as of Q3 2016.

  • Tygh Capital Management reported no remaining Pediatrix Medical position as of Q3 2016 after selling out during the quarter.
  • Tygh Capital Management sold 40,926 Pediatrix Medical shares in Q3 2016, an estimated $2.96M.
  • Tygh Capital Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 13 quarters.
  • Tygh Capital Management's Pediatrix Medical position peaked at $11.5M in Q2 2015.
  • 381 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2016.

Based on Tygh Capital Management's 13F filing for Q3 2016, filed 2 Nov 2016.